Home AllaChem

AllaChem

In operation
Seed Round Financing
Drug Developer

Basic Information

AllaChem aims to emphasize a rational approach that combines modern medicinal chemistry with streamlined preclinical and clinical development studies. The company’s drugs feature improved pharmacokinetics, efficacy, and safety profiles for the treatment of infectious diseases, cancer, and central nervous system (CNS) disorders, enabling physicians to treat their patients more effectively.
AllaChem
United States of America
unclear
January 01, 2004
--